NEWS

Cellaria and Biological Industries USA Partner on Stem Cell Media and Research
Yahoo Finance
The partnership combines BI-USA’s strength in stem cell culture media and manufacturing with Cellaria’s comprehensive Stem Cell Services program, which includes industry leading RNA reprogramming and custom differentiation services. Together, the …

and more »

Cellaria and Biological Industries USA Partner on Stem Cell Media and Research
Yahoo Finance
The partnership combines BI-USA’s strength in stem cell culture media and manufacturing with Cellaria’s comprehensive Stem Cell Services program, which includes industry leading RNA reprogramming and custom differentiation services. Together, the …

and more »

Vivet Raises €37.5M to Develop Gene Therapies for Rare Liver Diseases
Genetic Engineering & Biotechnology News
French startup Vivet Therapeutics raised €37.5 million (about $41 million) in a Series A round of financing to support the development of gene therapies for rare inherited metabolic diseases. The firm was set up in 2016 to develop treatments based on …
Swiss majors Roche and Novartis back gene therapy upstartFierceBiotech
Novartis, Roche back French gene therapy start-up VivetWHTC
French Gene Therapy Biotech Raises a Huge €37.5M in Series ALabiotech.eu (blog)
PR Newswire (press release) –The Pharma Letter (registration) –PR Newswire UK (press release)
all 11 news articles »

Cellaria and Biological Industries USA Partner on Stem Cell Media and Research
GlobeNewswire (press release)
As part of the agreement, Cellaria will distribute BI-USA’s stem cell media offering, including its NutriStem® hPSC Medium, a cGMP xeno-free media specifically designed for human pluripotent stem cell culture. Cellaria will also incorporate the product …

and more »

Swiss majors Roche and Novartis back gene therapy upstart
FierceBiotech
Newly born European biotech Vivet Therapeutics has started life with €37.5 million ($41 million) and an exec team made up of Novartis, Sanofi and Gensight vets, as the company looks to get to work on its gene therapies for a host of rare diseases …
News Vivet Raises €37.5M to Develop Gene Ther…Genetic Engineering & Biotechnology News
Novartis, Roche back French gene therapy start-up VivetWHTC
French Gene Therapy Biotech Raises a Huge €37.5M in Series ALabiotech.eu (blog)
PR Newswire (press release) –PR Newswire UK (press release) –Global University Venturing
all 10 news articles »

GARM Now Offering Elite Athletes Stem Cell Treatment with US Olympic Orthopedic Surgeon
Benzinga
Global Alliance for Regenerative Medicine, known as GARM, is now offering stem cell therapy for elite athletes with a US Olympic orthopedic surgeon Glenn Terry MD. The treatments are being offered in the Caribbean with extremely high cell counts for …
RoosterBio Launches the Regenerative Medicine Industry’s First Xeno-Free hMSC Cell Banks to Advance and Simplify …PR Web (press release)

all 3 news articles »

Novartis, Roche back French gene therapy start-up Vivet
WHTC
(Reuters) – French gene therapy start-up Vivet Therapeutics said on Thursday it had raised 37.5 million euros ($41 million) in an initial financing round, with backing from the venture arms of Swiss drugmakers Novartis and Roche. Other investors …
GenSight vet Combal grabs $40M from Novartis, Roche group for second-wave gene therapy biotechEndpoints News
Vivet Therapeutics Raises €37.5 Million in Series A Financing Round to Advance Novel Gene Therapies for Treating …PR Newswire (press release)

all 4 news articles »